Norepinephrine infusion increases urine output in children under sedative and analgesic infusion

Jefferson Piva1, Tamila Alquati2, Pedro Celiny Garcia2

  • 1Pediatric Emergency and Intensive Care Department, Hospital de Clínicas de Porto Alegre, UFRGS University, Porto Alegre, RS, Brazil.

Revista Da Associacao Medica Brasileira (1992)
|July 9, 2014
PubMed

Insights

Early norepinephrine (NE) infusion in mechanically ventilated children improved blood pressure and urine output. This intervention may counteract vasoplegia caused by sedative and analgesic drugs.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology

Background:

  • Mechanical ventilation (MV) in children often requires continuous sedative and analgesic infusions.
  • These infusions can induce vasoplegia, affecting hemodynamic stability.
  • Optimizing hemodynamic management in this population is crucial.

Purpose of the Study:

  • To assess the impact of early norepinephrine (NE) infusion on children undergoing mechanical ventilation.
  • To evaluate hemodynamic variables, fluid balance, and renal function in this context.

Main Methods:

  • A double-blinded, randomized, placebo-controlled trial was conducted in a Brazilian Pediatric Intensive Care Unit (PICU).
  • Children aged 1 month to 12 years requiring MV and sedation for at least five days were enrolled.
  • Participants received either NE (0.15 mcg/kg/min) or normal saline for 72 hours, initiated within 24 hours of MV.

Main Results:

  • Forty children were randomized; no significant differences in baseline characteristics or outcomes like mortality were observed.
  • The NE group demonstrated significantly higher urine output (p = 0.016).
  • Mean arterial pressure showed a significant continuous increment in the NE group compared to baseline (p = 0.043).

Conclusions:

  • Early administration of norepinephrine in mechanically ventilated children receiving sedatives and analgesics improves mean arterial pressure.
  • Norepinephrine infusion also led to increased urine output in this pediatric cohort.
  • These findings suggest NE can effectively reverse vasoplegia induced by sedative and analgesic agents.
Abstract

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
995
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400